H.Res. 484 — Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Summary

This resolution expresses the sense of the House of Representatives that the United States should not waive intellectual property protections for COVID-19 vaccines, treatments, or other related innovations.

Full Text

Legislative Actions

2021-06-17
Introduced in House
2021-06-17
Introduced in House
2021-06-17
Referred to the House Committee on the Judiciary.
2022-11-01
Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill